Biohaven Ltd. (NYSE:BHVN) is one of the Best 52-Week Low Stocks to Buy According to Analysts.. On June 10, Biohaven Ltd.

The first ever treatment for Australians with a rare neurodegenerative disease could help slow the progression of its damage ...

Biohaven Ltd. (NYSE:BHVN) is one of the best low priced pharma stocks to buy now. Earlier on June 10, Bexorg Inc., which is a ...

Cipla is preparing to enter the weight-loss drug making sector, heating the competition with US-based Eli Lilly & Co and ...

AI has been a buzzword in the pharmaceutical industry for almost a decade, with countless headlines promising to revolutionise how drugs are discovered, developed, and deployed.

Main Acetylcholine (ACh) was one of the first neurotransmitters to be discovered and is one of the most important in the central nervous system (CNS) and peripheral nervous system (PNS).

Market OverviewThe global Epilepsy Drugs Market is valued at USD 10.63 billion in 2024 and is projected to reach a value ...

Pharmaceutical giant Cipla plans to enter India's weight management sector, while also bolstering its central nervous system ...

Overview of Nanotechnology Drug Delivery MarketThe global Nanotechnology Drug Delivery Market is valued at USD 97.98 Billion ...

Infudopa SubC® is a user-friendly and minimally invasive alternative enabling flexible dosing and thereby empowering patients with greater independence DÜSSELDORF, Germany and GOTHENBURG ...

Medipal Holdings-JCR Pharmaceuticals’ JR-446 for mucopolysaccharidosis type IIIB recevies EC orphan drug designation: Tokyo Thursday, June 26, 2025, 15:00 Hrs [IST] Medipal Hold ...

(Alliance News) - Solvonis Therapeutics PLC on Friday said it raised GBP1.0 million gross from subscriptions to new shares, and this will fund development of drugs treating addiction and other mental ...